Abstract
BackgroundTo implement the newly updated 2025 European Society of Cardiology (ESC) modified World Health Organization (mWHO) 2.0 classification in a cohort of pregnant women with cardiovascular disease, and to evaluate the clinical impact of disease acuity, referral timing, and specialized maternal-fetal medicine (MFM) surveillance intensity on granular obstetric and neonatal outcomes.MethodsThis retrospective, observational cohort study analyzed 82 maternal-fetal dyads managed at a tertiary center. Patients were stratified into a Low-Risk Group (mWHO 2.0 Class I–II; n=40) and a Moderate-to-Extreme High-Risk Group (Classes II–III,III, and IV; n=42). Surveillance intensity was measured by referral timing and total MFM visits. Multivariate logistic and linear regression models were constructed to identify independent predictors of adverse perinatal endpoints.ResultsValvular disease predominated (54.9%). A paradoxical referral pattern emerged, with 71.4% of high-risk versus 50.0% of low-risk patients referred late (≥14 weeks; p=0.047). In multivariate logistic regression, high-risk mWHO 2.0 status was the sole independent predictor for preterm birth (aOR: 4.292, p=0.007) and NICU admission (aOR: 2.662, p=0.045). Multiple linear regression showed neonatal birth weight was uniquely governed by gestational age (p<0.001) and maternal age (p=0.014), rather than mWHO tier (p=0.675). The high-risk group had a 90.2% Cesarean rate (p=0.040).ConclusionThe 2025 mWHO 2.0 tier robustly predicts neonatal morbidity, which is iatrogenically driven by indicated preterm deliveries to prevent maternal failure. Systemic adjustments are required to improve late referral patterns and optimize early multidisciplinary care.